Sorry, you need to enable JavaScript to visit this website.
Skip to main content

Meeting the New Regulatory Requirements in Sartan API Production

Manufacturer of APIs are now required to review their manufacturing processes and prove the absence of nitrosamine impurities. This whitepaper outlines the regulations and a case study on how Dr. Reddy’s Sartan API’s (such as Valsartan) already addresses future requirements.


You can review our Sartan portfolio by clicking on the following links:

Valsartan -

Losartan -

Telmisartan -

Irbesartan -

Please fill the Contact form below in order to view the white paper

Email us: |   +91 40 49002253